| 1 |
Pedrosa MB, Barbosa S, Vitorino R, Ferreira R, Moreira-gonçalves D, Santos LL. Chemotherapy-Induced Molecular Changes in Skeletal Muscle. Biomedicines 2023;11:905. [DOI: 10.3390/biomedicines11030905] [Reference Citation Analysis]
|
| 2 |
Salaun H, Poisson M, Dolly A, Arbion F, Servais S, Dumas JF, Goupille C, Ouldamer L. Total Polyunsaturated Fatty Acid Level in Abdominal Adipose Tissue as an Independent Predictor of Recurrence-Free Survival in Women with Ovarian Cancer. Int J Mol Sci 2023;24. [PMID: 36675280 DOI: 10.3390/ijms24021768] [Reference Citation Analysis]
|
| 3 |
Fröhlich AK, Diek M, von Haehling S, Anker MS. Furnishing the cachexia landscape: A year of research in JCSM. J Cachexia Sarcopenia Muscle 2022;13:2763-71. [PMID: 36510825 DOI: 10.1002/jcsm.13151] [Reference Citation Analysis]
|
| 4 |
Yang J, Chen K, Zheng C, Chen K, Lin J, Meng Q, Chen Z, Deng L, Yu H, Deng T, Bo Z, He Q, Wang Y, Chen G. Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma. J Cachexia Sarcopenia Muscle 2022;13:2383-92. [PMID: 35854105 DOI: 10.1002/jcsm.13040] [Cited by in Crossref: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 5 |
Stelten S, Schofield C, Hartman YAW, Lopez P, Kenter GG, Newton RU, Galvão DA, Hoedjes M, Taaffe DR, van Lonkhuijzen LRCW, McIntyre C, Buffart LM. Association between Energy Balance-Related Factors and Clinical Outcomes in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) 2022;14. [PMID: 36230490 DOI: 10.3390/cancers14194567] [Reference Citation Analysis]
|
| 6 |
Shen Z, Liu Z, Zhang P, Chen W, Dong W, Chen W, Lin F, Zang W, Yan X, Yu Z. Prognostic significance of postoperative loss of skeletal muscle mass in patients underwent coronary artery bypass grafting. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.970729] [Reference Citation Analysis]
|
| 7 |
Cheng E, Kirley J, Cespedes Feliciano EM, Caan BJ. Adiposity and cancer survival: a systematic review and meta-analysis. Cancer Causes Control 2022. [PMID: 35971021 DOI: 10.1007/s10552-022-01613-7] [Reference Citation Analysis]
|
| 8 |
Mu J, Wu Y, Jiang C, Cai L, Li D, Cao J. Progress in Applicability of Scoring Systems Based on Nutritional and Inflammatory Parameters for Ovarian Cancer. Front Nutr 2022;9:809091. [DOI: 10.3389/fnut.2022.809091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Luan Y, Zhang Y, Yu SY, You M, Xu PC, Chung S, Kurita T, Zhu J, Kim SY. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study. J Cachexia Sarcopenia Muscle 2022;13:1289-301. [PMID: 35044098 DOI: 10.1002/jcsm.12864] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 10 |
Cai B, Li K, Li G. Impact of Obesity on Major Surgical Outcomes in Ovarian Cancer: A Meta-Analysis. Front Oncol 2022;12:841306. [PMID: 35223523 DOI: 10.3389/fonc.2022.841306] [Reference Citation Analysis]
|
| 11 |
Pin F, Jones AJ, Huot JR, Narasimhan A, Zimmers TA, Bonewald LF, Bonetto A. RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice. J Bone Miner Res 2022;37:381-96. [PMID: 34904285 DOI: 10.1002/jbmr.4480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Sutton EH, Plyta M, Fragkos K, Di Caro S. Pre-treatment sarcopenic assessments as a prognostic factor for gynaecology cancer outcomes: systematic review and meta-analysis. Eur J Clin Nutr 2022. [PMID: 35194194 DOI: 10.1038/s41430-022-01085-7] [Reference Citation Analysis]
|
| 13 |
Tranoulis A, Kwong FLA, Lakhiani A, Georgiou D, Yap J, Balega J. Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.02.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Tan S, Zhuang Q, Zhang Z, Li S, Xu J, Wang J, Zhang Y, Xi Q, Meng Q, Jiang Y, Wu G. Postoperative Loss of Skeletal Muscle Mass Predicts Poor Survival After Gastric Cancer Surgery. Front Nutr 2022;9:794576. [DOI: 10.3389/fnut.2022.794576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Chi M, Zhang H, Wang Y, Sun X, Yang Q, Guo C, Sakuma K. Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/5694223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Lee J, Lin J, Chen T, Jan Y, Sun F, Chen Y, Wu M. Progressive Skeletal Muscle Loss After Surgery and Adjuvant Radiotherapy Impact Survival Outcomes in Patients With Early Stage Cervical Cancer. Front Nutr 2022;8:773506. [DOI: 10.3389/fnut.2021.773506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Matsumoto C, Sekine H, Nahata M, Mogami S, Ohbuchi K, Fujitsuka N, Takeda H. Role of mitochondrial dysfunction in the pathogenesis of cisplatin-induced myotube atrophy. Biological & Pharmaceutical Bulletin. [DOI: 10.1248/bpb.b22-00171] [Reference Citation Analysis]
|
| 18 |
Fröhlich AK, Diek M, Denecke C, von Haehling S, Hadzibegovic S, Anker MS. JCSM: growing together with cachexia and sarcopenia research. J Cachexia Sarcopenia Muscle 2021;12:1359-67. [PMID: 34969163 DOI: 10.1002/jcsm.12886] [Reference Citation Analysis]
|
| 19 |
Scopel Poltronieri T, de Paula NS, Chaves GV. Skeletal muscle radiodensity and cancer outcomes: A scoping review of the literature. Nutr Clin Pract 2021. [PMID: 34752653 DOI: 10.1002/ncp.10794] [Reference Citation Analysis]
|
| 20 |
Chiang PK, Tsai WK, Chiu AW, Lin JB, Yang FY, Lee J. Muscle Loss During Androgen Deprivation Therapy Is Associated With Higher Risk of Non-Cancer Mortality in High-Risk Prostate Cancer. Front Oncol 2021;11:722652. [PMID: 34604058 DOI: 10.3389/fonc.2021.722652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 21 |
Li YX, Xia WW, Liu WY. The influence process of sarcopenia on female cancer: A systematic review and meta-analysis. J Obstet Gynaecol Res 2021;47:4403-13. [PMID: 34496449 DOI: 10.1111/jog.15012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Dolan RD, Abbass T, Sim WMJ, Almasaudi AS, Dieu LB, Horgan PG, McSorley ST, McMillan DC. Longitudinal Changes in CT Body Composition in Patients Undergoing Surgery for Colorectal Cancer and Associations With Peri-Operative Clinicopathological Characteristics. Front Nutr 2021;8:678410. [PMID: 34485358 DOI: 10.3389/fnut.2021.678410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Lee J, Chen TC, Jan YT, Li CJ, Chen YJ, Wu MH. Association of Patient-Reported Outcomes and Nutrition with Body Composition in Women with Gynecologic Cancer Undergoing Post-Operative Pelvic Radiotherapy: An Observational Study. Nutrients 2021;13:2629. [PMID: 34444789 DOI: 10.3390/nu13082629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 24 |
Yoshikawa T, Miyamoto M, Aoyama T, Matsuura H, Iwahashi H, Ishibashi H, Kakimoto S, Sakamoto T, Takasaki K, Suminokura J, Tsuda H, Kawaguchi H, Yoshino A, Takano M. Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancers. Mol Clin Oncol 2021;15:177. [PMID: 34276996 DOI: 10.3892/mco.2021.2339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 25 |
Kim HG, Huot JR, Pin F, Guo B, Bonetto A, Nader GA. Reduced rDNA transcription diminishes skeletal muscle ribosomal capacity and protein synthesis in cancer cachexia. FASEB J 2021;35:e21335. [PMID: 33527503 DOI: 10.1096/fj.202002257R] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 26 |
McSharry V, Glennon K, Mullee A, Brennan D. The impact of body composition on treatment in ovarian cancer: a current insight. Expert Rev Clin Pharmacol 2021;14:1065-74. [PMID: 34080491 DOI: 10.1080/17512433.2021.1937125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 27 |
Straughn AR, Kelm NQ, Kakar SS. Withaferin A and Ovarian Cancer Antagonistically Regulate Skeletal Muscle Mass. Front Cell Dev Biol 2021;9:636498. [PMID: 33718372 DOI: 10.3389/fcell.2021.636498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 28 |
Lee J, Liu SH, Chen JC, Leu YS, Liu CJ, Chen YJ. Progressive muscle loss is an independent predictor for survival in locally advanced oral cavity cancer: A longitudinal study. Radiother Oncol 2021;158:83-9. [PMID: 33621588 DOI: 10.1016/j.radonc.2021.02.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 29 |
Zhang H, Chi M, Chen L, Sun X, Wan L, Yang Q, Guo C. Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1/Akt/FoxO Pathway. Front Pharmacol 2020;11:598166. [PMID: 33390985 DOI: 10.3389/fphar.2020.598166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 30 |
Lee J, Liu SH, Dai KY, Huang YM, Li CJ, Chen JC, Leu YS, Liu CJ, Chen YJ. Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer. Laryngoscope 2021;131:E1530-8. [PMID: 33135827 DOI: 10.1002/lary.29221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 31 |
Fadadu PP, Polen-De CL, McGree ME, Weaver AL, Moynagh MR, Takahashi N, Langstraat CL, Cliby WA, Kumar A. Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation. Gynecol Oncol 2021;160:40-4. [PMID: 33109391 DOI: 10.1016/j.ygyno.2020.10.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 32 |
Lee YJ, Lee JY, Nam EJ, Kim SW, Kim S, Kim YT. Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy. J Clin Med 2020;9:E1235. [PMID: 32344611 DOI: 10.3390/jcm9041235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Huang CY, Yang YC, Chen TC, Chen JR, Chen YJ, Wu MH, Jan YT, Chang CL, Lee J. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer. J Cachexia Sarcopenia Muscle 2020;11:534-46. [PMID: 31999069 DOI: 10.1002/jcsm.12524] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 34 |
Siddiqui JA, Pothuraju R, Jain M, Batra SK, Nasser MW. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions. Biochim Biophys Acta Rev Cancer 2020;1873:188359. [PMID: 32222610 DOI: 10.1016/j.bbcan.2020.188359] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 35 |
Lee J, Lin JB, Wu MH, Chang CL, Jan YT, Chen YJ. Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer. Cancers (Basel) 2020;12:E595. [PMID: 32150938 DOI: 10.3390/cancers12030595] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
